I reported in May that Israeli biotech Compugen discovered 4 new protein variants that stimulate the immune system into targeting cancer cells. Now tests have shown that CGEN-15001T will fight carcinomas, sarcomas, melanoma and haematological cancers.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000721404&fid=1725